Healius Ltd
OTC:PHCRF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Healius Ltd
OTC:PHCRF
|
AU |
Intrinsic Value
The intrinsic value of Healius Ltd (PHCRF) under the Base Case is 3.24 USD per share. Compared with the current market price of 0.84 USD, the stock appears Undervalued by 74% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Healius Does
Healius is an Australian medical diagnostics company. It mainly earns money by running pathology services, which means collecting patient samples and testing them in labs for doctors, hospitals, and other healthcare providers. It also has interests in related diagnostic services, so it sits behind the scenes as part of the healthcare testing process rather than as a hospital or doctor group.
- Headquarters
- Australia AU
- Employees
- 8 000
- IPO date
- Jul 3, 1998
Healius has no economic moat
Healius Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Earnings Waterfall
Healius Ltd
The intrinsic value for Healius Ltd (PHCRF) under the Base Case is 3.24 USD.
Compared with the current market price of 0.84 USD, the stock appears Undervalued by 74% .